Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 12;10(11):2781.
doi: 10.3390/foods10112781.

Microbiological Quality and Resistance to an Artificial Gut Environment of Two Probiotic Formulations

Affiliations

Microbiological Quality and Resistance to an Artificial Gut Environment of Two Probiotic Formulations

Diletta Mazzantini et al. Foods. .

Abstract

The quality control of probiotic products is the focus of numerous organizations worldwide. Several studies have highlighted the poor microbiological quality of many commercial probiotic formulations in terms of the identity of the contained microorganisms, viability, and purity, thus precluding the expected health benefits and representing a potential health risk for consumers. In this paper, we analyzed the contents of two probiotic formulations, one composed of an encapsulated mixture of lactobacilli and bifidobacteria, and one by a lyophilized yeast. The microorganisms contained in the products were quantified and identified using up-to-date methodologies, such as MALDI-TOF MS and metagenomic analysis. Moreover, as acid and bile tolerance is included among the criteria used to select probiotic microorganisms, in vitro tests were performed to evaluate the behavior of the formulations in conditions mimicking the harsh gastric environment and the intestinal fluids. Our results indicate the high quality of the formulations in terms of the enumeration and identification of the contained organisms, as well as the absence of contaminants. Moreover, both products tolerated the acidic conditions well, with encapsulation providing further protection for the microorganisms. A good tolerance to the simulated artificial intestinal conditions was also evidenced for both preparations.

Keywords: gastrointestinal behavior; identification; probiotics; quality; viable cells.

PubMed Disclaimer

Conflict of interest statement

E.G. received research grants and/or travel grants and honoraria for speaking or participation at meetings from Novartis, OFF Italia, Polichem, and Sanofi S.r.l.; and R.L. is an employee of Sanofi Consumer Health Care, UK. This does not alter her adherence to food policies on sharing data and materials. D.M., F.C., M.C., and A.P. have no competing interests to declare.

Figures

Figure 1
Figure 1
Survival of microorganisms contained in Microbiosys (a) and Enterogermina Viaggi (b) in the ASTM- and USP-simulated gastric fluids at pH 1.5 and 3.0. Microbial counts were carried out at 0, 30, 60, and 120 min of incubation and expressed as Log CFUs. * p < 0.05.
Figure 2
Figure 2
Behavior of microbes contained in Microbiosys and Enterogermina Viaggi in simulated intestinal juice (pH 8.0). Microbial counts were carried out at 0, 30, 60, 120, 240, and 360 min, and expressed as Log CFUs. * p < 0.05, ** p < 0.01.

Similar articles

Cited by

References

    1. Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J. Expert consensus document. The international scientific association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014;11:506–514. doi: 10.1038/nrgastro.2014.66. - DOI - PubMed
    1. Goldstein E.J., Citron D.M., Claros M.C., Tyrrell K.L. Bacterial counts from five over-the-counter probiotics: Are you getting what you paid for? Anaerobe. 2014;25:1–4. doi: 10.1016/j.anaerobe.2013.10.005. - DOI - PubMed
    1. Fredua-Agyeman M., Parab S., Gaisford S. Evaluation of commercial probiotic products. Br. J. Pharm. 2016;1:84–89. doi: 10.5920/bjpharm.2016.11. - DOI
    1. Ansari J.M., Colasacco C., Emmanouil E., Kohlhepp S., Harriott O. Strain-level diversity of commercial probiotic isolates of Bacillus, Lactobacillus, and Saccharomyces species illustrated by molecular identification and phenotypic profiling. PLoS ONE. 2019;14:e0213841. doi: 10.1371/journal.pone.0213841. - DOI - PMC - PubMed
    1. Lugli G.A., Mangifesta M., Mancabelli L., Milani C., Turroni F., Viappiani A., van Sinderen D., Ventura M. Compositional assessment of bacterial communities in probiotic supplements by means of metagenomic techniques. Int. J. Food Microbiol. 2019;294:1–9. doi: 10.1016/j.ijfoodmicro.2019.01.011. - DOI - PubMed

Grants and funding

LinkOut - more resources